Hartline Investment Corp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-791
Closed -$359K 134
2022
Q3
$359K Buy
+791
New +$378K 0.3% 83

Other funds holding ELV

Hartline Investment Corp's ELV Position: Q4 2022 in Review

Hartline Investment Corp sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 791 shares — an estimated $359K sold.

Hartline Investment Corp first reported a position in ELV in Q3 2022 and held it in 1 quarter. The position peaked at $359K in Q3 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Hartline Investment Corp reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Hartline Investment Corp sold 791 Elevance Health shares in Q4 2022, an estimated $359K.
  • Hartline Investment Corp first reported a position in Elevance Health in Q3 2022 and held it in 1 quarter.
  • Hartline Investment Corp's Elevance Health position peaked at $359K in Q3 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Hartline Investment Corp's 13F filing for Q4 2022, filed 6 Feb 2023.